SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, Inc. today announced that the United Stated Patent and Trademark Office has granted US Patent #8,232,092 (July 31, 2012) “Light Transmitted Assay Beads,” describing the method of decoding barcodes and analyzing bioassays using Barcoded Magnetic Beads (BMB) multiplex products.
“The new patent expands our 3 earlier patents for polymer-based Barcoded Magnetic Beads by including the analytical multiplex system that is responsible for high accuracy and high sensitivity bioassays,” said Winston Ho, PhD, President of Applied BioCode. “These patents solidify our intellectual property portfolio by further protecting our encoded polymer bead technology and providing our products with long term market value.”
Applied BioCode’s new 12-digit Barcoded Magnetic Beads have 4,096 separate barcodes, enabling the simultaneous analysis of up to 4,096 DNA or protein targets in a single sample. Barcoded Magnetic Beads not only offer an all-in-one panel assay, but also for a higher level of automation and lower cost. The BioCode analyzers provide clinical and life science research laboratories with a wide variety of bioassay applications including personal medicine, oncology, infectious diseases, genetic assays and biomarker validation.
About Applied BioCode, Inc.
Applied BioCode, Inc., a privately held biotechnology company with headquarters located in Santa Fe Springs, California, develops, manufactures and markets products to assist those focused on molecular diagnostics, bioresearch and biomarkers validation. The BMB is a single platform which can be utilized from Biomarker Discovery directly to In-Vitro Diagnostics. This approach enables users to optimize efficiency and resources to help customers maximize the benefit of digital multiplexing.
